All In MedTech

Device Trial Radar · NCT06487312

Clinical Trial to Evaluate the Effectiveness and Safety of a Remote Automated Ultrasound Diagnostic System for Automated Ultrasound Examinations: a Prospective, Multicenter Study

Clinical Application of Multi-organ Multi-task Autonomous Ultrasound Embodied Intelligent Robot

Last checked: Nov 19, 2026Latest source record: Jul 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

1,000

Planned (sponsor's estimate)

Start

Jul 30, 2024

Primary completion

Mar 30, 2027

Study completion Jul 30, 2027

Sponsor

Lead sponsor
Tongji HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 5, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this clinical trial is to verify the safety and effectiveness of the remote automatic ultrasound diagnosis system produced by Wuhan Cooper Technology Co., Ltd. for automatic ultrasound examination. It aims to answer the main questions: Can the robot complete automatic ultrasound scanning of multiple systems and organs such as liver, gallbladder, spleen, pancreas, kidney, thyroid, carotid artery, etc.? Will there be medical safety issues during the robot\'s scanning process?

Conditions

  • Ultrasound
  • Thyroid
  • Carotid Artery
  • Liver
  • Gallbladder
  • Spleen
  • Pancreas
  • Kidney

Interventions

  • Test equipment: Name: Remote automatic ultrasound diagnostic system (Wuhan Cooper Technology Co., Ltd.) Model: CORUS-A30Device

    A clinical trial to evaluate the effectiveness and safety of a remote automated ultrasound diagnostic system for automated ultrasound examination using a remote automated ultrasound diagnostic system (model: CORUS-A30, Wuhan Cooper Technology Co., Ltd., China).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Image scanning pass rateTime frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Xin-Wu Cui

    Wuhan, Hubei, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.